Related Experiment Video
Updated: Jun 14, 2026

Basics of Multivariate Analysis in Neuroimaging Data
Published on: July 24, 2010
Analyses of diagnostic patterns at 30 Alzheimer's disease centers in the US
Kyle Steenland1, Jessica Macneil, Scott Bartell
1Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA. nsteenl@sph.emory.edu
Background:
The US Alzheimer's Disease Centers (ADCs) (n = 30) recently created a uniform data set. We sought to determine which variables were most important in making a diagnosis, and how these differed across ADCs.
Methods:
A cross-sectional analysis of first visits to ADCs via polytomous logistic regression. We analyzed subjects with complete data (n = 7,555, 89%), and also used multiple imputation to infer missing data.
Results:
There were 8,495 subjects; 50, 26, and 24% were diagnosed as normal, having mild cognitive impairment (MCI), or mild Alzheimer's disease [Clinical Dementia Rating (CDR) score <1], respectively. The model using 7,555 subjects was 86% accurate in predicting diagnosis. Important predictors were physician-reported decline and the CDR sum of boxes, followed by 4 cognitive tests (Mini Mental State Examination, Category Fluency Tests, Logical Memory Test, Boston Naming Test). Multiple imputation revealed Trail Making Test B to be additionally important. Consensus versus single-clinician diagnoses were 2-3 times more likely to result in MCI than normal diagnoses. Excluding clinical judgment variables, functional assessment and psychiatric symptoms were important additional predictors; model accuracy remained high (78%). There were significant differences between centers in the use of different cognitive tests in making diagnoses.
Conclusions:
We recommend creating a hypothetic data set to use across ADCs to improve diagnostic consistency, and a survey on the use of raw or adjusted cognitive test scores by different ADCs.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer's Disease: Treatment
Alzheimer Disease ll: Pathophysiology
Dementia l: Introduction
Dementia
The progression of dementia is generally gradual.
